Diagnostics & Diseases Market Research Reports & Industry Analysis

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 887 pages and 72 tables

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 891 pages and 75 tables

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 880 pages and 73 tables

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 886 pages and 67 tables

... . Profiles leading manufacturers and potential market entrants developing innovative technologies and products. Analyzes alternative market penetration strategies for suppliers. Methodology The report is based on a combination of primary and secondary information sources, including Venture Planning ...

... . Profiles leading manufacturers and potential market entrants developing innovative technologies and products. Analyzes alternative market penetration strategies for suppliers. Methodology The report is based on a combination of primary and secondary information sources, including Venture Planning ...

... . Profiles leading manufacturers and potential market entrants developing innovative technologies and products. Analyzes alternative market penetration strategies for suppliers. Methodology The report is based on a combination of primary and secondary information sources, including Venture Planning ...

... . Profiles leading manufacturers and potential market entrants developing innovative technologies and products. Analyzes alternative market penetration strategies for suppliers. Methodology The report is based on a combination of primary and secondary information sources, including Venture Planning ...

... . Profiles leading manufacturers and potential market entrants developing innovative technologies and products. Analyzes alternative market penetration strategies for suppliers. Methodology The report is based on a combination of primary and secondary information sources, including Venture Planning ...

... . Profiles leading manufacturers and potential market entrants developing innovative technologies and products. Analyzes alternative market penetration strategies for suppliers. Methodology The report is based on a combination of primary and secondary information sources, including Venture Planning ...

... leading suppliers and recent market entrants developing innovative technologies and products and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Contains 292 pages and 36 tables

... vitro fertilization is a type of assisted reproductive technology that helps women in conceiving. The global IVF market was valued at $9.3 billion in 2012 and ... can be created through medical tourism and availability of low cost IVF treatments. The companies profiled in this report include Vitrolife AB, Cooper ...

... and business expansion opportunities with significant market appeal. 'Ideal' product models with tentative prices and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains 405 pages and 35 tables

... and business expansion opportunities with significant market appeal. 'Ideal' product models with tentative prices and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains 406 pages and 38 tables

... and business expansion opportunities with significant market appeal. 'Ideal' product models with tentative prices and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains 402 pages and 35 tables

... and business expansion opportunities with significant market appeal. 'Ideal' product models with tentative prices and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains 402 pages and 35 tables

... and business expansion opportunities with significant market appeal. 'Ideal' product models with tentative prices and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains 400 pages and 37 tables

... and business expansion opportunities with significant market appeal. 'Ideal' product models with tentative prices and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains 409 pages and 35 tables

... and business expansion opportunities with significant market appeal. 'Ideal' product models with tentative prices and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains 424 pages and 37 tables

... DataPack (test volumes, sales forecasts, supplier shares) $4,300. '2014 Strategies for the French Microbiology Testing Market' is a new strategic analysis of major ... market during the next five years. The report examines key French market trends; reviews current and emerging assays; analyzes potential ...

... . DataPack (test volumes, sales forecasts, supplier shares) $4,300. '2014 Strategies for the German Microbiology Testing Market' is a new strategic analysis of major ... market during the next five years. The report examines key German market trends; reviews current and emerging assays; analyzes potential ...

... DataPack (test volumes, sales forecasts, supplier shares) $4,300. '2014 Strategies for the Italian Microbiology Testing Market' is a new strategic analysis of major ... market during the next five years. The report examines key Italian market trends; reviews current and emerging assays; analyzes potential ...

... DataPack (test volumes, sales forecasts, supplier shares) $5,700. '2014 Strategies for the Japanese Microbiology Testing Market' is a new strategic analysis of major ... market during the next five years. The report examines key Japanese market trends; reviews current and emerging assays; analyzes potential ...

... DataPack (test volumes, sales forecasts, supplier shares) $4,300. '2014 Strategies for the Spanish Microbiology Testing Market' is a new strategic analysis of major ... market during the next five years. The report examines key Spanish market trends; reviews current and emerging assays; analyzes potential ...

Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,300. '2014 Strategies for the UK Microbiology Testing Market' is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report ...

Complete report $9,850. DataPack (test volumes, sales forecasts, supplier shares) $6,400. '2014 Strategies for the US Microbiology Testing Market' is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report ...

... corporate strategies will be one of the most challenging tasks for diagnostic companies during the next ten years. Geographic Coverage France Germany ... years. Design criteria for new products. Alternative market penetration strategies. Potential market entry barriers and risks. Business planning issues ...

... strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 104 pages and 3 tables

... major tumor markers by country and market segment Profiles leading market players and potential entrants Suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs ...

... contains 398 pages, 29 tables, and presents a comprehensive analysis of the French hospital coagulation testing market, including: Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Volume and sales ...

... contains 394 pages, 28 tables, and presents a comprehensive analysis of the German hospital coagulation testing market, including: Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Volume and sales ...

... contains 394 pages, 28 tables, and presents a comprehensive analysis of the Italian hospital coagulation testing market, including: Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with significant market impact during the five five years. Volume and sales ...

... contains 392 pages, 28 tables, and presents a comprehensive analysis of the Japanese hospital coagulation testing market, including: Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Volume and sales ...

... contains 390 pages, 28 tables, and presents a comprehensive analysis of the Spanish hospital coagulation testing market, including: Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Volume and sales ...

... Group contains 402 pages, 28 tables, and presents a comprehensive analysis of the UK hospital coagulation testing market, including: Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Volume and sales ...

... 533 pages, 43 tables, and presents a comprehensive analysis of the French hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in French hospitals. Current instrumentation technologies and ...

... 530 pages, 40 tables, and presents a comprehensive analysis of the German hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in German hospitals. Current instrumentation technologies and ...

... 525 pages, 38 tables, and presents a comprehensive analysis of the Italian hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Italian hospitals. Current instrumentation technologies and ...

... 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Japanese hospitals. Current instrumentation technologies and ...

... 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Spanish hospitals. Current instrumentation technologies and ...

This new report from Venture Planning Group contains 527 pages, 37 tables, and presents a comprehensive analysis of the UK hospital tumor marker testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, ...

This new report from Venture Planning Group contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital tumor market ... , testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in US hospitals. Current instrumentation technologies and ...

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the French STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume ...

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the German STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume ...

About This Report This new 280-pages report from Venture Planning Group presents detailed analysis of the Italian STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume ...

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the Japanese STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume ...

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the Spanish STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume ...

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and ...

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and ...

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the French Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...